Skip to main content
Caplight Logo









Ethonova

Ethonova

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://etnova.co.kr

Last Round

Series A

Mar 1, 2022

Total Funding Raised

$4.26M

Company Overview

Ethonova is a medical device company that develops technologies for the treatment of sepsis and the prevention of cervical cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall-molecule therapeuticsdrug discoverybiotechhepatocellular carcinomatargeted anticancer therapyoncology drugmulti-tyrosine kinase inhibitormTKIclinical trialsischemic strokeneurodegenerative diseasespharma pipelinedrug out-licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ethonova Comparables

Compare Ethonova with similar companies based on industry and business-model similarity.

Ethonova comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rznomics Inc.
76%
Tempest Therapeutics
75%
HLB Co., Ltd.
74%

Ethonova Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 1, 2022
AngelOct 1, 2020

Ethonova Investors

Notable investors and investment history

Ethonova investors
InvestorRounds
Albatross InvestmentSeries A
Golden Oak Investment Co., Ltd.Series A
Enlight VenturesSeries A
IPS VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2022

    $4.26M round led by Albatross Investment.

  • Oct 1, 2020

    Completed an angel funding round.

Ethonova Filings

Explore SEC and related filing metadata, where available.

Ethonova filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ethonova's valuation, stock price, and market status.

Is Ethonova a public or private company?

Ethonova is a private company.

What is the current stock price of Ethonova?

Ethonova is a private company with no public stock price. Caplight tracks Ethonova's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Ethonova worth (valuation)?

Valuation information for Ethonova is not publicly available.

Can I buy Ethonova stock?

Ethonova shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ethonova's last funding round?

Ethonova's most recent funding round was Series A on March 1, 2022.

Who are the main investors in Ethonova?

Key investors in Ethonova include Albatross Investment.

Will Ethonova IPO soon?

No public IPO plans have been announced for Ethonova.

How can I track Ethonova secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ethonova's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2011
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?